We're still gathering social media discussions on this article. A synopsis appears once there are enough posts to summarize.
AgreementNeither agree nor disagree
InterestNeutral interest
EngagementNeutral engagement
ImpactNeutral impact
Abstract in brief
Recent advances in upstream continuous processing focus on improving the production of biopharmaceuticals like therapeutic proteins, viral vectors, and cell therapies through techniques such as perfusion, which involves maintaining high cell densities in bioreactors.
Innovations include optimizing operation strategies, enhancing cell density control with feed solutions, and integrating advanced monitoring tools like capacitance sensors and Raman spectroscopy to improve process efficiency and product quality.
These developments are not only applied to primary production but also extend to other upstream processes like cell bank preparation and seed bioreactor operations, aiming to make biopharmaceutical manufacturing more continuous, efficient, and scalable.]
Recent advances in upstream continuous processing focus on improving biopharmaceutical production through techniques such as perfusion, high cell densities, and real-time monitoring tools. These innovations aim to…
1 s2.0 S0958166922001628 Main | PDF | Biopharmaceutical | Viral ...
News
https://doi.org/10.1016/j.copbio.2022.102828 stream perfusion process [11] and traced historical progression from the early chemostat process to current
06 Maximizing Yield of Perfusion Cell Culture Processes Evaluation ...
News
... 10.1016/j. [17] D. Voisard, F. Meuwly, P.A. Ruffieux, G. Baer, A. Kadouri ... 91 (1991), https://doi.org/10.1016/C2013-0- copbio.2022.102828. 04523-9 ...